skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

60 Total results for product and free and sample content found

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

More Top Level Pharma Exits In India As Cipla COO Departs

06 Dec 2019

Cipla’s global chief operating officer is leaving the company to pursue new interests, amid a spate of top-level exits that have marked the pharma sector in India in 2019.

HBW Insight : コンシューマーヘルスケア産業のニュース

Novartis Wins Second Landmark German Case, This Time For Probiotics

13 Nov 2019

Following a landmark win against the German government for the Rx-to-OTC switch of desloratadine last month, Novartis has again secured a victory in the German Higher Court system, this time to continue marketing its Biosan probiotics range in the country.

Topic company-analysis policy-and-regulation

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Five Trials To Look Out For At The AHA Meeting

By Alex Shimmings 13 Nov 2019

Philadelphia is due to host the American Heart Association (AHA) meeting for the first time from 16-18 November, with the conference taking place in its condensed three-day format for just the second time. Scrip takes a look at the expected highlights.

Topic clinical-trials company-analysis research

Medtech Insight: 世界の医療機器・医療技術の最新情報

Laboratory For Advanced Medicine Appoints New CEO, Prepares To Scale Liquid Biopsy Pipeline

08 Nov 2019

With a new CEO at its helm, Laboratory for Advanced Medicine is preparing to take on the cancer-diagnostics market. Former AncestryDNA executive Kenneth Chahine has joined the company as it plans to drive global commercialization of its artificial intelligence liquid biopsy pipeline.

Topic cancer company-analysis

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Amarin's Vascepa Momentum Builds Ahead Of Next Week's FDA AdComm

By Jessica Merrill 06 Nov 2019

Sales of the triglyceride-lowering medicine soared to $112.4m in the third quarter even before a label expansion that depends on the outcome of a vital US FDA advisory committee meeting on 14 November.

Topic business-strategies company-analysis

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Second Spring? Coverage Expansion Fuels Big Pharma China Growth But '4+7' Impact Lingers

01 Nov 2019

AstraZeneca, Novartis and Roche deliver north of 20% sales growth in China again, driven by expanded reimbursement coverage and new product launches, but some clouds are on the horizon over falling sales due to the impact of the expanding “4+7” centralized procurement scheme.

Topic company-analysis

Biomedtracker: 開発中医薬品をFDA承認確率で評価

Major Mergers & Acquisitions Highlights from Q1 2019

24 Oct 2019

Major Mergers & Acquisitions Highlights from Q1 2019

Biomedtracker boils down all the important mergers and acquisitions activities in Q1.

Topic Business strategies Company analysis

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Woodford Debacle Is A Test Of UK Biotech's Resilience

By Andrew McConaghie 18 Oct 2019

Woodford Debacle Is A Test Of UK Biotech's Resilience

Investor's Downfall is Unwelcome Distraction: As once-star investment funds fail, another major investor argues this is opportunity for UK biotech to demonstrate staying power.

Topic BioPharmaceutical Company analysis

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。